Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Cell Carcinoma of Head and Neck
×
amivantamab
×
Clear all
Filters
3
NCT07276399
2026-03-13
OrigAMI-5
Janssen Research & Development, LLC
Phase 3
Recruiting
500 enrolled